Audit of diagnostic mammography examinations at the Centro de Diagnóstico Mamario de la Asociación Española (Center for Breast Diagnosis of the Asociación Española)

  • Gustavo Febles Asociación Española, Centro de Diagnóstico Mamario (CENDIMA). Médico imagenólogo
  • Fernando Estellano Asociación Española, Centro de Diagnóstico Mamario (CENDIMA). Médico cirujano
  • Oscar Simón Asociación Española, Centro de Diagnóstico Mamario (CENDIMA). Médico imagenólogo
Keywords: BREAST NEOPLASMS, MAMMOGRAPHY, AUDIT

Abstract

Objective: to evaluate the performance of diagnostic mammography at the "Centro de Diagnóstico Mamario (CENDIMA) of the Asociación Española".
Method: we calculated the positive predictive value, cancer detection rate, cancer minimum percentage, average size of the invading cancer, negative axilla percentage and percentages for stages 0 and I.
Results were compared to reference parameters provided by the Breast Cancer Surveillance Consortium (BCSC).
Results: positive predictive value of all positive mammographies BI-RADS 4 and 5 was 62% (over P90 according to the BCSC database).
Positive predictive value of all biopsies actually performed was 55% (P75 to P90). Cancer detection rate was 9 /1,000 (< P10).
Minimum percentage was 36% (P25 to P50).
130 invasive cancer cases were diagnosed, average size was 10 mm (P25 a P50).
Negative axilla percentage was 72% (P50 to P75).
Stage 0 and stage I cancer percentage was 61% (P50).
Conclusions: parameters found indicate CENDIMA’s performance, in terms of breast cancer, agrees with most centers for breast diagnosis in the United States.
Cancer detection rate is low for a diagnosis center, due to the fact that the population studied is mainly comprised of asymptomatic women.

References

(1) Monsees BS. The mammography quality standards act: an overview of the regulations and guidance. Radiol Clin North Am 2000; 38:759-72.
(2) Sickles E. Quality assurance: how to audit your own mammography practice. Radiol Clin North Am 1992; 30:265-75.
(3) Feig S. Auditing and benchmarks in screening and diagnostic mammography. Radiol Clin North Am 2007; 45(5):791-800.
(4) National Cancer Institute. Breast Cancer Surveillance Consortium (BCSC). Disponible en: http://breastscreening. cancer.gov/benchmarks/diagnostic. [Consulta: 18 marzo 2008].
(5) Sickles E, Miglioretti D, Ballard-Barbash R, Geller B, Leung J, Rosenberg R, et al. Performance benchmarks for diagnostic mammography. Radiology 2005; 235:775-90.
(6) Sohlich R, Sickles E, Burnside E, Dee K. Interpreting data from audits when screening and diagnostic mammography outcomes are combined. AJR Am J Roentgenol 2002; 178(3):681-6.
(7) Dee K, Sickles E. Medical audit of diagnostic mammography examinations: comparison with screening outcomes obtained concurrently. AJR Am J Roentgenol 2002; 176(3):729-33.
(8) D’Orsi CJ, Bassett LW, Berg WA. Breast imaging reporting and data system: ACR BI-RADS. 4 ed. Reston: American College of Radiology, 2003: 229-51.
(9) Horvath J, Milans S, Méndez G. 10 años del servicio de imagenología mamaria del Hospital Universitario: resultados auditados. Rev Imagenología 2006; 9(2):36-40.
(10) Horvath J, Krivianski N, Bianco C. Resultados auditados. Servicio de Imagenología Mamaria CASMU. Rev Imagenología 2006; 10(1):41-5.
Published
2009-03-31
How to Cite
1.
Febles G, Estellano F, Simón O. Audit of diagnostic mammography examinations at the Centro de Diagnóstico Mamario de la Asociación Española (Center for Breast Diagnosis of the Asociación Española). Rev. Méd. Urug. [Internet]. 2009Mar.31 [cited 2024Nov.17];25(1):5-13. Available from: http://www2.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/474